129 related articles for article (PubMed ID: 25128853)
1. Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
Muller C; Mazel V; Dausset C; Busignies V; Bornes S; Nivoliez A; Tchoreloff P
Eur J Pharm Biopharm; 2014 Nov; 88(3):787-94. PubMed ID: 25128853
[TBL] [Abstract][Full Text] [Related]
2. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Camares O; Paquet-Gachinat M; Bornes S; Forestier C; Veisseire P
J Biotechnol; 2012 Aug; 160(3-4):236-41. PubMed ID: 22542933
[TBL] [Abstract][Full Text] [Related]
3. Importance of pressure plasticity during compression of probiotic tablet formulations.
Byl E; Bladt P; Lebeer S; Kiekens F
Eur J Pharm Biopharm; 2019 Dec; 145():7-11. PubMed ID: 31605741
[TBL] [Abstract][Full Text] [Related]
4. Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Veisseire P; Alaterre E; Dausset C; Baptiste F; Camarès O; Paquet-Gachinat M; Bonnet M; Forestier C; Bornes S
Appl Microbiol Biotechnol; 2015 Jan; 99(1):399-411. PubMed ID: 25280746
[TBL] [Abstract][Full Text] [Related]
5. Elastic recovery of filler-binders to safeguard viability of Lactobacillus rhamnosus GG during direct compression.
Byl E; Lebeer S; Kiekens F
Eur J Pharm Biopharm; 2019 Feb; 135():36-43. PubMed ID: 30543948
[TBL] [Abstract][Full Text] [Related]
6. Strain-specific differences in behaviour among Lacticaseibacillus rhamnosus cell wall mutants during direct compression.
Byl E; Jokicevic K; Kiekens S; Lebeer S; Kiekens F
Int J Pharm; 2020 Oct; 588():119755. PubMed ID: 32783980
[TBL] [Abstract][Full Text] [Related]
7. Comparative phase I randomized open-label pilot clinical trial of Gynophilus
Dausset C; Patrier S; Gajer P; Thoral C; Lenglet Y; Cardot JM; Judlin P; Ravel J; Nivoliez A
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1869-1880. PubMed ID: 30032443
[TBL] [Abstract][Full Text] [Related]
8. Oral probiotic treatment of Lactobacillus rhamnosus Lcr35
Darbaky Y; Evrard B; Patrier S; Falenta J; Garcin S; Tridon A; Dapoigny M; Silberberg C; Nivoliez A; Diop L
J Appl Microbiol; 2017 Jan; 122(1):188-200. PubMed ID: 27718511
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations.
Muller C; Busignies V; Mazel V; Forestier C; Nivoliez A; Tchoreloff P
PLoS One; 2013; 8(11):e79041. PubMed ID: 24244412
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
Poupet C; Saraoui T; Veisseire P; Bonnet M; Dausset C; Gachinat M; Camarès O; Chassard C; Nivoliez A; Bornes S
PLoS One; 2019; 14(11):e0216184. PubMed ID: 31693670
[TBL] [Abstract][Full Text] [Related]
11. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
[TBL] [Abstract][Full Text] [Related]
12. Development of tablets containing probiotics: Effects of formulation and processing parameters on bacterial viability.
Klayraung S; Viernstein H; Okonogi S
Int J Pharm; 2009 Mar; 370(1-2):54-60. PubMed ID: 19059323
[TBL] [Abstract][Full Text] [Related]
13. Elemental sulfur enhances the anti-fungal effect of Lacticaseibacillus rhamnosus Lcr35.
Kaur M; Miquel S; Ollivier-Nakusi L; Thoral C; Vareille-Delarbre M; Bekirian C; d'Enfert C; Fontaine T; Roget K; Forestier C
Microbes Infect; 2024; 26(3):105286. PubMed ID: 38160785
[TBL] [Abstract][Full Text] [Related]
14. Oral Delivery of Probiotics Using pH-Sensitive Phthalyl Inulin Tablets.
Kim WS; Cho CS; Hong L; Han GG; Kil BJ; Kang SK; Kim DD; Choi YJ; Huh CS
J Microbiol Biotechnol; 2019 Feb; 29(2):200-208. PubMed ID: 30691251
[TBL] [Abstract][Full Text] [Related]
15. Oral Delivery of Probiotics in Poultry Using pH-Sensitive Tablets.
Jiang T; Li HS; Han GG; Singh B; Kang SK; Bok JD; Kim DD; Hong ZS; Choi YJ; Cho CS
J Microbiol Biotechnol; 2017 Apr; 27(4):739-746. PubMed ID: 28081355
[TBL] [Abstract][Full Text] [Related]
16. Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect.
Park HJ; Lee GH; Jun J; Son M; Kang MJ
Drug Des Devel Ther; 2016; 10():1355-64. PubMed ID: 27103789
[TBL] [Abstract][Full Text] [Related]
17. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Coudeyras S; Jugie G; Vermerie M; Forestier C
Infect Dis Obstet Gynecol; 2008; 2008():549640. PubMed ID: 19190778
[TBL] [Abstract][Full Text] [Related]
18. Compression physics in the formulation development of tablets.
Patel S; Kaushal AM; Bansal AK
Crit Rev Ther Drug Carrier Syst; 2006; 23(1):1-65. PubMed ID: 16749898
[TBL] [Abstract][Full Text] [Related]
19. Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism
Poupet C; Veisseire P; Bonnet M; Camarès O; Gachinat M; Dausset C; Chassard C; Nivoliez A; Bornes S
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31878039
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35.
Evrard B; Coudeyras S; Dosgilbert A; Charbonnel N; Alamé J; Tridon A; Forestier C
PLoS One; 2011 Apr; 6(4):e18735. PubMed ID: 21533162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
